OCC Trading, page-1686

There is heavy manipulation of the OCC share price, if I recall correctly their was an ASIC article where OCC was identified as one of the securities that was being manipulated by algo trading. Will try and dig up the article.

I think the LT prospects for OCC are only now starting the materialise given the last 5+ years has been focused on clinical validation and trials.
It's only recently that OCC have started adding some growth onto the revenue line (granted last quarter was unimpressive).

It's always disheartening to look at a small cap investment during June, the selling is 100% due to investors writing off losses and shuffling money around. This will be above 40c when the next quarter drops. If revenues show more growth then it could be the catalyst it needs to finally break the 40c resistance.